More Scrutiny Means Strict Regulation and Opportunity
Pharmacists can lead to the charge to innovate in both 503A and 503B settings, which are poised to change and grow.
Outpatient ASPs Are Worth the Journey
Developing an antimicrobial stewardship program is arduous but valuable; commitment from leadership is the first step.
Improve Care for Patients With Community-Acquired Pneumonia
Empiric anti-MRSA therapy is an area of opportunity for antimicrobial stewardship in the treatment of CAP.
Explore Ovarian Cancer Treatments Through Clinical Trials
Guidelines typically recommend debulking surgery, plus systemic chemotherapy for most patients.
COVID-19 Pandemic Forces Changes in Breast Cancer Treatment
Modifications include high rates of neoadjuvant endocrine chemotherapy, genomic assay testing on core biopsies, and delays in planned surgeries.
Change Management Is a Consideration Beyond the Pandemic
Thoughtful application can reduce resistance and improve overall operations, if consistent steps are followed.
CIDP Has a Complex Pathophysiology and Path to Diagnosis
Early recognition and treatment, along with a coordinated approach and multidisciplinary team, are important to limit disease progression.
COVID-19 Vaccinations: It Takes a Village
The pharmacy community has stepped up mightily to ensure this massive health care effort is successful.
New Technologies Boost Pharmacist's Role
Digital health products and solutions expand ways to guide prevention and treatment.
340B Program Compliance Tools Vary in Ability, Accuracy
Technology is essential, but not all solutions meet every goal or offer the same capabilities.
Digital Technology Has Changed the Landscape
COVID-19 is fueling the expansion of treatment methods beyond medications to include digital therapeutics.
2 Clarke Drive Cranbury, NJ 08512